| abstract |
(57) [Problem] To provide a medicament for combination therapy of prostatic hyperplasia, which can reduce undesirable side effects. The present invention provides a medicament for treating or preventing benign prostatic hyperplasia, wherein the medicament comprises an active ingredient selected from the group consisting of a 17β-hydroxysteroid dehydrogenase inhibitor and an aromatase inhibitor. In the medicament, one active ingredient of the 17β-hydroxysteroid dehydrogenase inhibitor and the aromatase inhibitor is for use in combination with administration of the other active ingredient. |